Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.

Raghavender Boothpur, Stephanie Torrence, Daniel C. Brennan

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.'. Together they form a unique fingerprint.